Skip to main content
. Author manuscript; available in PMC: 2009 Aug 1.
Published in final edited form as: Biochimie. 2008 Apr 4;90(8):1233–1249. doi: 10.1016/j.biochi.2008.03.011

Table 1.

Cytotoxicities of HXDV and HXLV-AC versus RPMI 8402 Human Lymphoblast and KB3-1 Human Oral Carcinoma Cellsa

Compound RPMI 8402
IC50 (µM)		 KB3-1
IC50 (µM)
HXDV 0.4 ± 0.1 0.4 ± 0.1
HXLV-AC 0.8 ± 0.3 0.9 ± 0.2
a

Cytotoxicities were determined by standard MTT assay after four days of continuous compound exposure, and are reported as the compound concentrations at which cellular growth is 50% inhibited (IC50).